Effects of the Opiate Antagonist, Naltrexone, on Binging Antecedents and Plasma β-Endorphin Concentrations
- 1 June 1994
- journal article
- case report
- Published by Elsevier in Journal of the American Academy of Child & Adolescent Psychiatry
- Vol. 33 (5) , 748-752
- https://doi.org/10.1097/00004583-199406000-00016
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Cardiovascular and Other Physical Effects of Acute Administration of Naltrexone in Autistic ChildrenJournal of Child and Adolescent Psychopharmacology, 1993
- A possible role of proopiomelanocortin peptides in self-injurious behaviorProgress in Neuro-Psychopharmacology and Biological Psychiatry, 1990
- A Placebo-Controlled, Double-Blind Crossover Study of Naltrexone Hydrochloride in Outpatients with Normal Weight BulimiaJournal of Clinical Psychopharmacology, 1989
- Naltrexone in Autistic Children: An Acute Open Dose Range Tolerance TrialJournal of the American Academy of Child & Adolescent Psychiatry, 1989
- Ontogeny ofβ-Endorphin and Cortisol in the Plasma of Children and Adolescents*Journal of Clinical Endocrinology & Metabolism, 1988
- Naltrexone decreases self‐injurious behaviorAnnals of Neurology, 1987
- A preliminary study of beta endorphin during chronic naltrexone maintenance treatment in ex-opiate addictsLife Sciences, 1986
- Development and validation of a test for bulimia.Journal of Consulting and Clinical Psychology, 1984
- The Eating Attitudes Test: psychometric features and clinical correlatesPsychological Medicine, 1982
- Naltrexone, an Antagonist for the Treatment of Heroin DependenceArchives of General Psychiatry, 1973